Trial NCT04649060

View at ClinicalTrials.gov 
Org. Study IDs: OP-108
Secondary IDs: 2019-002161-36

Last trial update was posted on 2023-06-08

MeSH Interventions

Daratumumab Dexamethasone Melphalan

MeSH Conditions

Multiple Myeloma Neoplasms, Plasma Cell

Other Conditions

Relapsed Multiple Myeloma Relapsed-Refractory Multiple Myeloma

Stopping Reasons

The sponsor decided to terminate the study due to financial issues following an FDA request for a partial clinical hold.

Limitations And Caveats

This study was put on clinical hold and later discontinued prematurely. Due to this, there is limited data available, and data cleaning was not done according to the original plan. Due to the early termination, the response assessments were done by investigators, not by an independent review committee.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID